Back to results
US 2022/0015728 A1Published application
Methods and systems to determine cancer molecular subtypes based on ultrasound and/or optoacoustic (oa/us) features
AssigneeSeno Medical Instruments, Inc.
InventorAnthony Thomas Stavros
Life of this patent
Estimating the term…
Abstract
Methods, devices and systems are provided that utilize one or more processors in connection with, receiving OA/US feature scores in connection with OA/US images collected from a patient examination for a volume of interest. The methods, devices and systems apply the OA/US feature scores to a feature score to molecular subtype (FSMS) model. The methods, devices and systems determine, from the FSMS model, an indication of at least one of a molecular subtype or histologic grade of a pathology experienced by the patient.
Claims18
A method, comprising:
- utilizing one or more processors in connection with,
- receiving OA/US feature scores in connection with OA/US images collected from a patient examination for a volume of interest;
- applying the OA/US feature scores to a feature score to molecular subtype (FSMS) model;
- and
- determining, from the FSMS model, an indication of at least one of a molecular subtype or histologic grade of a pathology experienced by the patient.
2 more elements
A system, comprising:
- memory configured to store program instructions and a feature score to molecular subtype (FSMS) model;
- one or more processors that, when executing the program instructions, or configured to:
- receive the OA/US feature scores comprises in connection with OA/US images collected from a patient examination for a volume of interest;
- apply the OA/US feature scores to the FSMS model;
- and
- determine, from the FSMS model, an indication of at least one of a molecular subtype or histologic grade of a pathology experienced by the patient.
3 more elements
Dependencies are inferred from the claim text.